- Home
- LUV vs NEUP Comparison
LUV vs NEUP Comparison
Compare LUV & NEUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUV
- NEUP
- Stock Information
- Founded
- LUV 1967
- NEUP 1996
- Country
- LUV United States
- NEUP United States
- Employees
- LUV N/A
- NEUP N/A
- Industry
- LUV Air Freight/Delivery Services
- NEUP
- Sector
- LUV Consumer Discretionary
- NEUP
- Exchange
- LUV Nasdaq
- NEUP Nasdaq
- Market Cap
- LUV 18.3B
- NEUP 17.4B
- IPO Year
- LUV N/A
- NEUP N/A
- Fundamental
- Price
- LUV $29.80
- NEUP $4.88
- Analyst Decision
- LUV Hold
- NEUP Strong Buy
- Analyst Count
- LUV 17
- NEUP 1
- Target Price
- LUV $32.02
- NEUP $21.00
- AVG Volume (30 Days)
- LUV 8.5M
- NEUP 1.6M
- Earning Date
- LUV 01-30-2025
- NEUP 02-14-2025
- Dividend Yield
- LUV 2.42%
- NEUP N/A
- EPS Growth
- LUV N/A
- NEUP N/A
- EPS
- LUV 0.75
- NEUP N/A
- Revenue
- LUV $27,483,000,000.00
- NEUP $662,715.00
- Revenue This Year
- LUV $7.14
- NEUP N/A
- Revenue Next Year
- LUV $5.23
- NEUP N/A
- P/E Ratio
- LUV $39.49
- NEUP N/A
- Revenue Growth
- LUV 5.34
- NEUP N/A
- 52 Week Low
- LUV $23.58
- NEUP $2.12
- 52 Week High
- LUV $36.12
- NEUP $15.72
- Technical
- Relative Strength Index (RSI)
- LUV 37.32
- NEUP N/A
- Support Level
- LUV $29.74
- NEUP N/A
- Resistance Level
- LUV $30.85
- NEUP N/A
- Average True Range (ATR)
- LUV 0.77
- NEUP 0.00
- MACD
- LUV 0.01
- NEUP 0.00
- Stochastic Oscillator
- LUV 24.51
- NEUP 0.00
About LUV Southwest Airlines Company
Southwest Airlines is the largest domestic air carrier in the United States by passengers boarded. Southwest operates over 800 aircraft in an all-Boeing 737 fleet. Despite offering some longer routes and a few perks for business travelers, the airline predominantly specializes in short-haul, leisure flights operated in a single, open-seating cabin configuration in a point-to-point network. In 2025, Southwest will modify its cabins to offer some seats with extra legroom and will update its ticketing process to offer assigned seats.
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.